Amedisys (AMED 1.20%), a leading provider of home health, hospice, and high acuity post-acute care services, reported quarterly earnings for the period ending June 30, 2025, on July 29, 2025. The most significant news is that the company outperformed market expectations on both revenue and adjusted profitability, even as merger-related costs weighed on GAAP results. GAAP revenue reached $621.9 million, ahead of the$611.99 million GAAP consensus, and Non-GAAP EPS was $1.54, well over the$1.36 analyst forec ...